Peter H. Sugden is at the National Heart and Lung Institute (Cardiac Medicine), Imperial College of Science, Technology and Medicine, London SW3 6LY, United Kingdom.
Trends Cardiovasc Med. 1996 Apr;6(3):87-94. doi: 10.1016/1050-1738(96)00013-8.
Endothelin-1 (ET-1) is a locally acting vasoactive peptide that also has profound effects on the contractile properties and growth of the cardiac myocyte. Binding of ET-1 to its transmembrane heptahelical receptors activates G proteins of the G(q) and G(i) classes. Activation of G(q) stimulates hydrolysis of phosphatidylinositol-4,5-bisphosphate, and the diacylglycerol thus formed stimulates protein kinase C. Subsequently, the protein kinase Raf is activated and this leads to activation of the extracellular signal-regulated protein kinase (ERK) subfamily of mitogen-activated protein kinases. Activation of G(i) counteracts β-adrenoceptor-mediated increases in cAMP concentrations. We have attempted to rationalize the established physiological consequences of ET-1 agonism in the cardiac myocyte (that is, on contraction and growth) in terms of activation of these signaling pathways.
内皮素-1(ET-1)是一种局部作用的血管活性肽,对心肌细胞的收缩特性和生长也有深远的影响。ET-1 与其跨膜七螺旋受体结合,激活 G(q)和 G(i)两类 G 蛋白。G(q)的激活刺激磷脂酰肌醇-4,5-二磷酸的水解,由此形成的二酰基甘油刺激蛋白激酶 C。随后,蛋白激酶 Raf 被激活,这导致细胞外信号调节蛋白激酶(ERK)亚家族的丝裂原激活蛋白激酶的激活。G(i)的激活抵消了β-肾上腺素能受体介导的 cAMP 浓度的增加。我们试图根据这些信号通路的激活来合理化 ET-1 激动剂在心肌细胞中产生的既定生理后果(即收缩和生长)。